BioSpace News Archive

Achieve Life Sciences Announces Presentations at Upcoming Investor Conferences

Achieve Life Sciences, Inc. announced that John Bencich, Chief Financial and Operating Officer, will present at two upcoming investor conferences.

September 4, 2019
·
1 min read
Business

Alpha Tau Medical Appoints Jefferson University Radiation Oncologist Robert Den as Chief Medical Officer

Alpha Tau Medical announced the appointment of Dr. Robert B. Den, MD, as Chief Medical Officer (CMO). In his new role, and as a prominent expert and accomplished clinician, Dr. Den will lead the clinical research functions for Alpha Tau, furthering the company mission of innovation in cancer therapy.

September 4, 2019
·
3 min read
Genetown

Leap Therapeutics to Present at Upcoming Investor Conferences

Leap Therapeutics, Inc., a biotechnology company developing targeted and immuno-oncology therapeutics, announced that Christopher K. Mirabelli, Ph.D., Chairman, President and Chief Executive Officer, will present a corporate overview at the following investor conferences

September 4, 2019
·
2 min read
Biotech Bay

HighTech Business Decisions’ New Biopharmaceutical Contract Manufacturing Pricing Study Shows Higher Overall Production Prices

HighTech Business Decisions has just published its new study: “Biopharmaceutical Contract Manufacturing: Best Practices Pricing Study 2019.”

September 4, 2019
·
1 min read
Drug Development

Rocket Pharmaceuticals Announces Registration-Enabling Phase 2 Plans for RP-L102 Gene Therapy for Fanconi Anemia Following a Supportive End-of-Phase 1 FDA Meeting

U.S. Phase 2 Trial to Use MMC-Resistance as Primary Endpoint, Supported by Additional Blood Count, Genetic and Phenotypic Assessments

September 4, 2019
·
8 min read
Pharm Country

More Than 100 Bristol-Myers Squibb Employees Embark on Coast 2 Coast 4 Cancer Ride to Help Advance Groundbreaking Cancer Research

10-year cancer survivor Dana Vaughns joins colleagues in cross-country cycling relay with a goal to raise more than $1 million for the V Foundation for Cancer Research

September 4, 2019
·
5 min read
Business

STAAR Surgical Announces Strategic Alliance Agreement with Asian Eye Institute

World Class Eye Institute Positions ICL as Primary and Premium Vision Correction Procedure

September 4, 2019
·
5 min read
Biotech Bay

OPKO Health Switches to Multichannel Veeva CRM to Drive More Effective Customer Engagement

Veeva CRM empowers pharmaceutical field representatives with the right information they need to deliver a personalized customer experience

September 4, 2019
·
4 min read
Biotech Bay

Monoclonal Antibody Therapeutics to Drive the Biotherapeutics Market

Pharmaceutical manufacturing operations call for new technologies to solve challenges in the harvest, clarification, and purification processes of mAbs production, finds Frost & Sullivan

September 4, 2019
·
3 min read
Drug Development

Tiziana Life Sciences Reports Positive Phase 2a Clinical Data Exhibiting Positive Clinical Activity with Milciclib Monotherapy in Advanced Sorafenib-refractory or -intolerant Patients with Unresectable or Metastatic Hepatocellular Carcinoma

The trial enrolled 31 patients in Italy, Greece and Israel, of which 28 patients were evaluable. While the primary endpoint of this study was overall safety, secondary endpoints were also evaluated.

September 4, 2019
·
9 min read